EnteroBiotix completes new manufacturing facility focused on gut microbiome therapiesnews2021-10-27T15:17:15+00:00October 27th, 2021|Fierce Pharma|
Johnson & Johnson inks $297M opioid deal with Texas as national deal faces holdoutsnews2021-10-27T15:06:03+00:00October 27th, 2021|Fierce Pharma|
Teva’s Austedo, struggling from a pandemic slowdown, needs huge gains to meet 2021 projectionsnews2021-10-27T13:51:35+00:00October 27th, 2021|Fierce Pharma|
FDA panel recommends Pfizer’s COVID-19 vaccine for kids, setting it up for approvalnews2021-10-27T13:33:36+00:00October 27th, 2021|Fierce Pharma|
Merck marks a first with global health org to license its COVID-19 pillnews2021-10-27T13:33:13+00:00October 27th, 2021|Fierce Pharma|
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growthnews2021-10-26T15:08:30+00:00October 26th, 2021|Fierce Pharma|
Democrats opposed to drug price reform are among those who received the most in donations from the pharma industry: reportnews2021-10-26T14:30:16+00:00October 26th, 2021|Fierce Pharma|
Catalent antes up $230M to expand Maryland viral vector manufacturing operationnews2021-10-26T13:45:48+00:00October 26th, 2021|Fierce Pharma|
Novartis hit with DOJ probe into Entresto marketing all while dialing up peak sales estimatenews2021-10-26T13:00:53+00:00October 26th, 2021|Fierce Pharma|
Ligand licenses prodrug tech to oral COVID-19 antiviral projectnews2021-10-26T12:54:26+00:00October 26th, 2021|Fierce Pharma|
